首页> 外文期刊>Archives of medical research >Intramyocardial Autologous Bone Marrow-derived Stem Cells Injection for Ischemic Heart Disease Ineligible for Revascularization: A Systematic Review and Meta-analysis
【24h】

Intramyocardial Autologous Bone Marrow-derived Stem Cells Injection for Ischemic Heart Disease Ineligible for Revascularization: A Systematic Review and Meta-analysis

机译:心肌内自体骨髓干细胞注射治疗不适合进行血运重建的缺血性心脏病:系统评价和荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background and Aims. Intramyocardial autologous bone marrow-derived stem cells injection (IM-BMCs) has been used in patients with ischemic heart disease (IHD) who are ineligible for revascularization; however, the procedure has yielded mixed results. The objective of this meta-analysis was to evaluate the safety and therapeutic benefits of this treatment on a relatively large scale.
机译:背景和目标。心肌内自体骨髓干细胞注射(IM-BMC)已用于不适合进行血管重建的缺血性心脏病(IHD)患者;但是,该过程产生了不同的结果。这项荟萃分析的目的是在相对较大的规模上评估这种治疗方法的安全性和治疗益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号